Table 3.
The combinations of clinical parameters to predict the occurrence of the cardiovascular events.
| Rank | The combination of clinical parameters | Adjusted p-value | |||
|---|---|---|---|---|---|
| 1 | The use of inotropic agents | 0.00071 | |||
| 2 | The use of diuretics | The use of inotropic agents | 0.00071 | ||
| 3 | The use of diuretics | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00071 | |
| 4 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00071 | ||
| 5 | The use of diuretics | In nyha class iii or ivat admission | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.00237 | |
| 6 | The use of diuretics | In nyha class iii or ivat admission | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00237 |
| 7 | The use of diuretics | In nyha class iii or ivat admission | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | Living with family members in the same household | 0.00262 |
| 8 | The use of inotropic agents | In nyha class iii or ivat admission | 0.00383 | ||
| 9 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | In nyha class iii or ivat admission | 0.00383 | |
| 10 | The use of diuretics | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | In nyha class iii or ivat admission | 0.00383 |
| 11 | The use of diuretics | The use of inotropic agents | In nyha class iii or ivat admission | 0.00383 | |
| 12 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | 0.00383 | ||
| 13 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00383 | |
| 14 | The use of diuretics | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00383 |
| 15 | The use of diuretics | The use of inotropic agents | The abnormal value of lvds (34 mm <) at admission | 0.00383 | |
| 16 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | 0.00383 | ||
| 17 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00383 | |
| 18 | The use of diuretics | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00383 |
| 19 | The use of diuretics | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | 0.00383 | |
| 20 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | 0.00383 | ||
| 21 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00383 | |
| 22 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00383 |
| 23 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | 0.00383 | |
| 24 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | 0.00871 | ||
| 25 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvds (34 mm <) at admission | 0.00871 | |
| 26 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of BNP (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00871 |
| 27 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The use of diuretics | The abnormal value of lvds (34 mm <) at admission | 0.00871 |
| 28 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of BNP (18.4 pg/ml <) at discharge | 0.00871 | |
| 29 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The use of diuretics | The abnormal value of BNP (18.4 pg/ml <) at discharge | 0.00871 |
| 30 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The use of diuretics | 0.00871 | |
| 31 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00871 | |
| 32 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00871 |
| 33 | The use of diuretics | The use of inotropic agents | The abnormal value of lvds (34 mm <) at admission | The abnormal value of lvds (34 mm <) at discharge | 0.00871 |
| 34 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00871 | |
| 35 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00871 |
| 36 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00871 |
| 37 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | 0.00871 | |
| 38 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.00871 |
| 39 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | The abnormal value of BNP (18.4 pg/ml <) at discharge | 0.00871 |
| 40 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | The use of diuretics | 0.00871 |
| 41 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00871 | |
| 42 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00871 |
| 43 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.00871 |
| 44 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | 0.00871 | ||
| 45 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00871 | |
| 46 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.00871 |
| 47 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | 0.00871 | |
| 48 | The use of diuretics | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.01388 | ||
| 49 | The use of inotropic agents | With leg edema | 0.01857 | ||
| 50 | The use of inotropic agents | With leg edema | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.01857 | |
| 51 | The use of diuretics | The use of inotropic agents | With leg edema | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.01857 |
| 52 | The use of diuretics | The use of inotropic agents | With leg edema | 0.01857 | |
| 53 | The use of diuretics | The abnormal value of bnp (18.4 pg/ml <) at discharge | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.01873 | |
| 54 | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.0196 | ||
| 55 | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.0196 | |
| 56 | The use of diuretics | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.0196 |
| 57 | The use of diuretics | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.0196 | |
| 58 | The use of inotropic agents | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at admission | 0.0196 | |
| 59 | The use of inotropic agents | In nyha class iii or ivat admission | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 60 | The use of diuretics | The use of inotropic agents | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 61 | The use of inotropic agents | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at discharge | 0.0196 | |
| 62 | The use of inotropic agents | In nyha class iii or ivat admission | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 63 | The use of diuretics | The use of inotropic agents | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 64 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | 0.0196 | |
| 65 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvds (34 mm <) at admission | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 66 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of BNP (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 67 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The use of diuretics | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 68 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | In nyha class iii or ivat admission | 0.0196 | |
| 69 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | In nyha class iii or ivat admission | 0.0196 |
| 70 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | In nyha class iii or ivat admission | 0.0196 |
| 71 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvds (34 mm <) at admission | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 72 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 73 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 | |
| 74 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 75 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 76 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 | |
| 77 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 78 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 79 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 80 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | 0.0196 | ||
| 81 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.0196 | |
| 82 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 83 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 84 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.0196 |
| 85 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.0196 |
| 86 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 | |
| 87 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 88 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 89 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.0196 |
| 90 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 | |
| 91 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 92 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.0196 |
| 93 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.0196 | |
| 94 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.0196 |
| 95 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | 0.0196 | |
| 96 | The use of inotropic agents | With leg edema | In nyha class iii or ivat admission | 0.04253 | |
| 97 | The use of inotropic agents | With leg edema | The abnormal value of bnp (18.4 pg/ml <) at discharge | In nyha class iii or ivat admission | 0.04253 |
| 98 | The use of diuretics | The use of inotropic agents | With leg edema | In nyha class iii or ivat admission | 0.04253 |
| 99 | The use of inotropic agents | Living with family members in the same household | 0.04356 | ||
| 100 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | Living with family members in the same household | 0.04356 | |
| 101 | The use of diuretics | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | Living with family members in the same household | 0.04356 |
| 102 | The use of diuretics | The use of inotropic agents | Living with family members in the same household | 0.04356 | |
| 103 | The use of inotropic agents | The use of beta-blockers | 0.04356 | ||
| 104 | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The use of beta-blockers | 0.04356 | |
| 105 | The use of diuretics | The use of inotropic agents | The abnormal value of bnp (18.4 pg/ml <) at discharge | The use of beta-blockers | 0.04356 |
| 106 | The use of diuretics | The use of inotropic agents | The use of beta-blockers | 0.04356 | |
| 107 | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of lvds (34 mm <) at admission | 0.04356 | |
| 108 | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 109 | The use of diuretics | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 110 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | In NYHA class III or ivat admission | 0.04356 | |
| 111 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvds (34 mm <) at admission | In NYHA class III or ivat admission | 0.04356 |
| 112 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of BNP (18.4 pg/ml <) at discharge | In NYHA class III or ivat admission | 0.04356 |
| 113 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The use of diuretics | In NYHA class III or ivat admission | 0.04356 |
| 114 | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of lvds (34 mm <) at discharge | 0.04356 | |
| 115 | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of bnp (18.4 pg/ml <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 116 | The use of diuretics | The use of inotropic agents | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 117 | The use of inotropic agents | The abnormal value of lvds (34 mm <) at discharge | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 118 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.04356 | |
| 119 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.04356 |
| 120 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | 0.04356 |
| 121 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 122 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | In NYHA class III or ivat admission | 0.04356 |
| 123 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | In nyha class iii or ivat admission | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 124 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | In nyha class iii or ivat admission | 0.04356 | |
| 125 | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | In nyha class iii or ivat admission | 0.04356 |
| 126 | The use of diuretics | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | In nyha class iii or ivat admission | 0.04356 |
| 127 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 | |
| 128 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 129 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of BNP (18.4 pg/ml <) at discharge | 0.04356 |
| 130 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The use of diuretics | 0.04356 |
| 131 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 132 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 | |
| 133 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 134 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 |
| 135 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 136 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.04356 |
| 137 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 |
| 138 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 | |
| 139 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 140 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 141 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 |
| 142 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of BNP (18.4 pg/ml <) at discharge | 0.04356 |
| 143 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of lvdd (52 mm <) at discharge | The use of diuretics | 0.04356 |
| 144 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 | |
| 145 | The abnormal value of %FS (<30%) at admission | The use of inotropic agents | The abnormal value of %FS (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 |
| 146 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at admission | 0.04356 |
| 147 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvds (34 mm <) at discharge | 0.04356 |
| 148 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of lvdd (52 mm <) at discharge | 0.04356 |
| 149 | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of lvdd (52 mm <) at discharge | The abnormal value of bnp (18.4 pg/ml <) at discharge | 0.04356 |
| 150 | The use of diuretics | The use of inotropic agents | The abnormal value of %fs (<30%) at discharge | The abnormal value of LVDd (52 mm <) at discharge | 0.04356 |
| 151 | The use of diuretics | Without either tachycardia (100 bpm <) or bradycardia(<50 bpm) | Living with family members in the same household | 0.04969 | |